Ditchcarbon
  • Contact
  1. Organizations
  2. Kobayashi Pharmaceuticals
Public Profile
Pharmaceutical Preparation Manufacturing
JP
updated 5 days ago

Kobayashi Pharmaceuticals

Company website

Kobayashi Pharmaceuticals Co., Ltd., commonly known as Kobayashi, is a leading player in the pharmaceutical and consumer healthcare industry, headquartered in Japan. Established in 1907, the company has a rich history marked by innovation and growth, with significant operations across Asia and beyond. Kobayashi is renowned for its diverse range of products, including over-the-counter medications, personal care items, and health supplements. Their unique formulations and commitment to quality set them apart in a competitive market. With a strong focus on research and development, Kobayashi has achieved notable milestones, solidifying its position as a trusted name in healthcare. The company continues to excel, leveraging its expertise to meet the evolving needs of consumers, while maintaining a reputation for excellence in product efficacy and safety.

DitchCarbon Score

How does Kobayashi Pharmaceuticals's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

30

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

33

Industry Benchmark

Kobayashi Pharmaceuticals's score of 30 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.

52%

Let us know if this data was useful to you

Kobayashi Pharmaceuticals's reported carbon emissions

In 2022, Kobayashi Pharmaceutical Co., Ltd. reported significant carbon emissions, with Scope 1 emissions at 6,000,000 kg CO2e, Scope 2 emissions at 18,000,000 kg CO2e (market-based), and a substantial 551,000,000 kg CO2e in Scope 3 emissions. The company has set ambitious climate commitments, aiming to reduce absolute Scope 1 and 2 greenhouse gas emissions by 51% by 2030 from a 2018 baseline. Additionally, it targets a 15% reduction in absolute Scope 3 emissions within the same timeframe. These targets align with the Science Based Targets initiative (SBTi) and are designed to support global efforts to limit warming to 1.5°C. Kobayashi's commitment reflects a proactive approach to addressing climate change within the consumer durables sector, demonstrating a clear strategy for emissions reduction and sustainability.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20182019202020212022
Scope 1
6,635,000
0,000,000
0,000,000
0,000,000
0,000,000
Scope 2
23,036,000
00,000,000
00,000,000
00,000,000
00,000,000
Scope 3
-
-
-
-
000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Kobayashi Pharmaceuticals's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Kobayashi Pharmaceuticals is in JP, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Kobayashi Pharmaceuticals is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

SC Johnson

US
•
Food products nec
Updated 2 months ago

Regeneron

US
•
Pharmaceutical Preparation Manufacturing
Updated 6 days ago

Johnson And Johnson

US
•
Pharmaceutical Preparation Manufacturing
Updated about 20 hours ago

Novartis

CH
•
Pharmaceutical Preparation Manufacturing
Updated about 4 hours ago

Merck And Co

US
•
Pharmaceutical Preparation Manufacturing
Updated about 20 hours ago

Biogen

US
•
Pharmaceutical Preparation Manufacturing
Updated about 20 hours ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251022.6
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy